Merck – $5.5 billion of disputed tax

Posted on

The Wall Street Journal has reported that the US drug company Merck has no less than $5.58 billion of tax disputes open with the IRS.

The company has just over $6 billion in cash reserves.

This sort of revelation, which has massive impact on the potential value of the company, more than justifies the disclosure of tax risk previously referred to on this site and for which the Tax Justice Network lobbied. And it also explains why the corporate world did not want such disclosure.


Thanks for reading this post.
You can share this post on social media of your choice by clicking these icons:

You can subscribe to this blog's daily email here.

And if you would like to support this blog you can, here: